Viewing Study NCT05399550


Ignite Creation Date: 2025-12-24 @ 5:23 PM
Ignite Modification Date: 2026-02-22 @ 4:23 AM
Study NCT ID: NCT05399550
Status: WITHDRAWN
Last Update Posted: 2023-08-07
First Post: 2022-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate The Safety and Efficacy of Balovaptan in Participants With Acute Ischemic Stroke at a High Risk of Developing Malignant Brain Edema
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module